Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam tosylate combined with propofol for painless gastrointestinal endoscopy in elderly patients
ChiCTR2300074918Phase 4Not yet recruiting
- Sponsor
- Ningjin County People's Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and alfentanil in None (2 arms), sponsored by Ningjin County People's Hospital. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 4 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
remimazolampropofolalfentanil
Beyond the preview
Go deeper on ChiCTR2300074918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074918.